openPR Logo
Press release

Colon Carcinoma Therapeutics Market Value Chain Analysis and Forecast Up to 2024

01-30-2018 11:08 AM CET | Health & Medicine

Press release from: Transparency Market Research

Colon Carcinoma Therapeutics Market Value Chain Analysis

Colon carcinoma is one of the most commonly occurring cancer type around the globe, it is usually developed in parts of the large intestine such as colon or rectum. The underlining cause of the cancer is an abnormal growth of cells in the parts of the large intestine due to certain cellular mutation. These cancer cells often lead to the growth of tumor in the respective area and are capable of invading other parts of the body. People over the age of 50 are more prone to the disease as incidence ratio is high amongst the geriatric population. Higher consumption of junked food, red meat and processed meat and lack of physical activity are linked with colon carcinoma. Health experts also suggest obesity, excessive smoking and consumption of alcohol as other factors that may cause the disease.

Report Overview @ https://www.transparencymarketresearch.com/colon-carcinoma-therapeutics-market.html

Few of the symptoms include blood in the stool, abnormal bowel movements, constipation weakness, vomiting, weight loss and nausea. At times, colon carcinoma may also root other complications such as inflammatory bowel disorders.

Higher emphasis on further development of anti-carcinogenic drugs is expected to deliver some promising outcomes in the near future. Currently, colon carcinoma has four common treatment modules namely chemotherapy, immunotherapy, targeted therapy and laparoscopic surgery. In the recent years, laparoscopic surgery has become more popular as the treatment is less painful delivering greater results.

Increasing geriatric population and changing lifestyle are the major cause of the disease. Being one of the most commonly occurring cancers, the demand for its treatment is growing at a significant rate. Further, increasing awareness and early diagnosis are expected to fuel the global colon carcinoma therapeutics market in the near future. The demand for anti-carcinogenic drugs and therapies in many of the Asian countries is growing at a healthy pace and is expected to favor the overall market. With each coming year, the number of incidences is increasing and is considered as a major factor driving the global market.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14777

On the other hand, despite increasing research and medicinal advancements, a complete cure for the disease is still not available. Biomedical researchers, scientist and health experts have seen success in extending the life expectancy of the patients, however, mortality rate still remains high in most cases. Other factors curtailing the growth of the market include high-cost of treatment, adverse side effects and credibility of drugs. Apart from these, long durations of research and heavy financial investments required for conducting preclinical research and development programs are major concerns for the pharmaceutical companies supplying colon carcinoma drugs.

Most patients receiving cancer treatments are subjected to severe side effects such as weight loss, hair loss and extreme weakness. Hence, drug manufacturers are highly focusing on enhancing the conventional methods of treatment. Over the past few years, a range of novel anti-carcinogenic drugs has introduced in the market by different brands. Furthermore, advanced screening test and surgery techniques such as robotic surgery has come up and are considered beneficial for the global colon carcinoma therapeutics market in the coming years.

On the basis of region, the global colon carcinoma therapeutics market has been segmented into six key regions namely North America, Western Europe, Eastern Europe, Latin America, Asia Pacific (APAC), and the Middle East & Africa (MEA). North America is considered one of the largest markets of colon carcinoma therapeutics. In addition, the U.S. accounted for more than one million new cases of colon carcinoma in 2015 and the number is expected to increase with each coming year.

Pre-Book Full Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=14777<ype=S

Few of the key players identified in the global colon carcinoma therapeutics market include Novartis International AG, F. Hoffmann-La Roche AG, AMGen, Celgene Corporation, Bristol-Myers Squibb, Merck & Co., Inc.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Colon Carcinoma Therapeutics Market Value Chain Analysis and Forecast Up to 2024 here

News-ID: 922162 • Views: 142

More Releases from Transparency Market Research

Subsea Well Access System Market In-depth qualitative insights, historical data, …
Global Subsea Well Access System Market: Overview The global subsea well access system market is primarily driven by plummeting production from the oil and gas reserves together with ageing offshore fields. A quick shift toward subsea regions is the emerging trend in oil and gas production sector, marking an important divergence from the usual methods of production. Some of the subsea environment exists in most unexplored and extremely remote parts of
Nicotinic Acid Market Size, Share, Growth, Trends, and Forecast 2027
Overview The research report provides valuable insights into demand drivers, geographical outlook, and competitive landscape of the Nicotinic Acid Market for the 2019-2027 forecast period. Further, it throws light on restraints as well discusses opportunities at length that are likely to come to the fore over the forecast period. The analysis thus provided helps Market stakeholders with business planning and to gauge scope of expansion in the Nicotinic Acid Market over
1 – Decene Market Growth Analysis, Share, Demand By Regions 2027
Overview The research report provides valuable insights into demand drivers, geographical outlook, and competitive landscape of the 1 – Decene Market for the 2019-2027 forecast period. Further, it throws light on restraints as well discusses opportunities at length that are likely to come to the fore over the forecast period. The analysis thus provided helps Market stakeholders with business planning and to gauge scope of expansion in the 1 – Decene
Steep Slope Roofing Materials Market Analysis, Size, Share, Growth, Trends, and …
Overview The research report provides valuable insights into demand drivers, geographical outlook, and competitive landscape of the 1 – Decene Market for the 2019-2027 forecast period. Further, it throws light on restraints as well discusses opportunities at length that are likely to come to the fore over the forecast period. The analysis thus provided helps Market stakeholders with business planning and to gauge scope of expansion in the 1 – Decene

All 5 Releases


More Releases for Colon

Colon Cleansing Supplements Market by Key Players - Vita Balance, PRIVATELABELSU …
Global Colon Cleansing Supplements Market: Snapshot Colon cleansing is essential if one needs to lose a few pounds of weight, solve acne problems, or improve their digestive system. There are several supplements are now available that adequately match the requirements and according to the findings of this study, the demand for them would be expanding profitably over the course of 2017 to 2027, gaining traction from increased awareness levels among the
Colon Cancer Market Prevalent Opportunities upto 2021
Colon cancer is the cancer of large intestine which form the lower part of the digestive system. The disease usually begins with a small, benign clusters of cells known as adenomatous polyps. If left untreated, these polyps may result into colon cancer. Therefore, regular screening for polyps through colonoscopy in order to prevent it transforming to colon cancer is recommended. Change in bowel habits or blood in stool are the
Global Therapeutic Landscape Of Colon Cancer Industry Pipeline Review, 2017
Overview Colon cancer is cancer that starts in the large intestine (colon). There is no single cause of colon cancer. Nearly all colon cancers begin as noncancerous (benign) polyps, which slowly develop into cancer. Many cases of colon cancer have no symptoms. The following symptoms may indicate colon cancer abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, or other change in bowel habits, narrow stools
Colon Cancer Market Perceive Robust Expansion by 2021
Colon cancer is the cancer of large intestine which form the lower part of the digestive system. The disease usually begins with a small, benign clusters of cells known as adenomatous polyps. If left untreated, these polyps may result into colon cancer. Therefore, regular screening for polyps through colonoscopy in order to prevent it transforming to colon cancer is recommended. Change in bowel habits or blood in stool are the
Colon Cancer Therapeutic Pipeline Market Review, H2 2017
Summary Colon cancer is cancer that starts in the large intestine (colon). There is no single cause of colon cancer. Nearly all colon cancers begin as noncancerous (benign) polyps, which slowly develop into cancer. Many cases of colon cancer have no symptoms. The following symptoms may indicate colon cancer abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, or other change in bowel habits, narrow stools
Colon Cancer - Pipeline Review, H1 2017
Report Hive Market Research Released a New Research Report of 745 pages on Title " Colon Cancer - Pipeline Review, H1 2017 "with detailed Analysis, Forecast and Strategies. Colon Cancer - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colon Cancer - Pipeline Review, H1 2017, provides an overview of the Colon Cancer (Oncology) pipeline landscape. Colon cancer is cancer that starts in the large intestine (colon).